NBTX Stock Analysis: Buy, Sell, or Hold?
NBTX - Nanobiotix S.A. American Depositary Shares
$39.15
-0.92 (-2.30%)
▼
5d:
-4.74%
30d:
+16.69%
90d:
+29.04%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Apr 28, 2026
0d
Get Alerted When NBTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NBTX trades at premium valuation expecting 48.1% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: NBTX trades at premium valuation expecting 48.1% growth. Hold existing positions but don't chase. Wait for better entry.
In-depth Analysis How we analyze
Valuation Analysis: NBTX is currently trading at $39.15, which is considered extended relative to its 30-day fair value range of $34.84 to $38.80. From a valuation perspective, the stock is trading at a premium (Forward PE: 579.1) compared to its historical average (178.3). At these levels, the market is pricing in 48.1% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, NBTX is in a uptrend. Immediate support is located at $35.26, while resistance sits at $42.92.
Market Sentiment: NBTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $48.48 (+23.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NBTX is in a uptrend. Immediate support is located at $35.26, while resistance sits at $42.92.
Market Sentiment: NBTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $48.48 (+23.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$34.84 -
$38.80
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.8% below Wall St target ($48.48)
- BEARISH: Market expects 48.1% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$34.84 -
$38.80
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$35.26
Resistance Level
$42.92
Current Trend
Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
579.14
Wall Street Target
$48.48
(+23.8%)
Revenue Growth (YoY)
186.8%
Profit Margin
-73.5%
Valuation Premium vs History
+48.1% premium
PE vs Historical
579.1 vs 178.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+48.1%
(market-implied from PE analysis)
1-Year Target
$57.98
(+48%)
2-Year Target
$85.87
(+119%)
3-Year Target
$127.17
(+225%)
3-Yr Target (if PE normalizes)
(PE: 579→178)
PE COMPRESSION
$39.15
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 579.1, Growth: 59.1%)
$132.13
(+238%)
Base:
(SPY PE: 21.8, Growth: 59.1%)
$4.97
(-87%)
Bear:
(PE: 18.5, Growth: 59.1%)
$4.22
(-89%)
Share & Embed Analysis
Last updated: July 14, 2026 1:21 AM ET
Data refreshes hourly during market hours. Next update: 2:21 AM
Data refreshes hourly during market hours. Next update: 2:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NBTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 61 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
